Found: 679
Select item for more details and to access through your institution.
Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 505, doi. 10.1007/s10557-022-07421-0
- By:
- Publication type:
- Article
Is Sacubitril/Valsartan a Superior Agent in Heart Failure With Reduced Ejection Fraction? A Review of Randomized Comparative Trials.
- Published in:
- Hospital Pharmacy, 2024, v. 59, n. 3, p. 282, doi. 10.1177/00185787231212619
- By:
- Publication type:
- Article
Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 3, p. 708, doi. 10.1177/08971900231177202
- By:
- Publication type:
- Article
Comparison of effects of telmisartan versus valsartan on post-induction hypotension during noncardiac surgery: a prospective observational study.
- Published in:
- Korean Journal of Anesthesiology, 2024, v. 77, n. 3, p. 335, doi. 10.4097/kja.23658
- By:
- Publication type:
- Article
SCENARIO.
- Published in:
- Australian Journal of Pharmacy, 2024, v. 105, n. 1238, p. 88
- Publication type:
- Article
LIQUID AND SOLID SELF-EMULSIFYING DRUG DELIVERY SYSTEMS (SEDDS) CONTAINING VALSARTAN: STABILITY ASSESSMENT AND PERMEABILITY STUDIES.
- Published in:
- Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2024, v. 48, n. 2, p. 525, doi. 10.33483/jfpau.1385707
- By:
- Publication type:
- Article
Valsartan Mitigates the Progression of Methotrexate-Induced Acute Kidney Injury in Rats via the Attenuation of Renal Inflammation and Oxidative Stress.
- Published in:
- Journal of Inflammation Research, 2024, v. 17, p. 2233, doi. 10.2147/JIR.S456610
- By:
- Publication type:
- Article
Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 2, p. 495, doi. 10.1177/08971900221142686
- By:
- Publication type:
- Article
The Salutary Effects of Diminazene, Lisinopril or Valsartan on Cisplatin - Induced Acute Kidney Injury in Rats: A Comparative Study.
- Published in:
- Physiological Research, 2024, v. 73, n. 2, p. 227, doi. 10.33549/physiolres.935210
- By:
- Publication type:
- Article
The Efficacy and Safety of Sacubitril/Valsartan Compared to Valsartan in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fractions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1572, doi. 10.3390/jcm13061572
- By:
- Publication type:
- Article
Patients with heart failure and reduced ejection fraction after sacubitril/valsartan treatment may be at risk for major adverse cardiovascular events according to ΔRDW.
- Published in:
- Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2024, v. 15, n. 3, p. 602
- By:
- Publication type:
- Article
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 3, p. 390, doi. 10.3390/pharmaceutics16030390
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study.
- Published in:
- Lipids in Health & Disease, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12944-024-02051-x
- By:
- Publication type:
- Article
Real-World evidence revelations: The potential of patient support programmes to provide data on medication usage.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0295226
- By:
- Publication type:
- Article
Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure.
- Published in:
- Heart & Vessels, 2024, v. 39, n. 2, p. 95, doi. 10.1007/s00380-023-02311-3
- By:
- Publication type:
- Article
A Multi-Analyte LC–MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.
- Published in:
- Journal of Chromatographic Science, 2024, v. 62, n. 2, p. 147, doi. 10.1093/chromsci/bmac059
- By:
- Publication type:
- Article
A Supercritical Fluid Chromatography and Tandem Mass Spectrometry Method for the Simultaneous Quantification of Valsartan and Hydrochlorothiazide in Human Plasma.
- Published in:
- Pharmaceutical Chemistry Journal, 2024, v. 57, n. 11, p. 1833, doi. 10.1007/s11094-024-03086-1
- By:
- Publication type:
- Article
Reverse Docking, Molecular Dynamics Simulation, and Network Analysis Studies to Investigate Potential Antihypertensive Side Effects of Valsartan and Lisinopril.
- Published in:
- Philippine Journal of Science, 2024, v. 153, n. 1, p. 415
- By:
- Publication type:
- Article
Comparative renoprotection: Sacubitril/valsartan versus ACEI or ARB - A systematic review and meta-analysis.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2024, v. 23, n. 2, p. 447, doi. 10.4314/tjpr.v23i2.27
- By:
- Publication type:
- Article
Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1321095
- By:
- Publication type:
- Article
Knowledge domain and emerging trends in sacubitril/valsartan study from 2008 to 2023 -- a visualized conclusive analysis based on novel scientometric tools.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 2, p. 502
- By:
- Publication type:
- Article
Comparison of the efficacy of combining left bundle branch pacing with either sacubitril/valsartan or enalapril in the treatment of chronic heart failure: A retrospective observational analysis.
- Published in:
- Pakistan Journal of Medical Sciences, 2024, v. 40, n. 3, Part 2, p. 265, doi. 10.12669/pjms.40.3.8520
- By:
- Publication type:
- Article
A neonate with a spongy failing heart -- What could it be?
- Published in:
- Annals of Pediatric Cardiology, 2024, v. 17, n. 1, p. 81, doi. 10.4103/apc.apc_193_23
- By:
- Publication type:
- Article
Decrease in Mycophenolic Acid Plasma Level by Sacubitril/Valsartan in a Lupus Nephritis Patient: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 1, p. 118, doi. 10.1002/psp4.13062
- By:
- Publication type:
- Article
Case Series: Sacubitril/Valsartan Role for Chemotherapy-Induced Cardiotoxicity: An in-Depth Investigation in Saudi Arabia.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Tween 80-Based Self-Assembled Mixed Micelles Boost Valsartan Transdermal Delivery.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 1, p. 19, doi. 10.3390/ph17010019
- By:
- Publication type:
- Article
Influence of PEG‐PLGA nanoparticles on the pore structure of injectable and self‐healing hydrogels based on carboxymethyl chitosan/aldehyde sodium hyaluronate for prolonged sustained release of valsartan.
- Published in:
- Polymers for Advanced Technologies, 2024, v. 35, n. 1, p. 1, doi. 10.1002/pat.6200
- By:
- Publication type:
- Article
COMPARISON OF EFFECTIVENESS OF ISOSORBID DINITRATE/HYDRALAZINE COMBINATION WITH SACUBITREL/VALSARTAN IN CHF AMONG INDIAN PATIENTS.
- Published in:
- Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2023, v. 14, n. 12, p. 1719
- By:
- Publication type:
- Article
Effect of Multidrug Resistance Gene and AGTR1 (1166A>C) Gene Polymorphism on Hypertension and Its Relationship with Antihypertensive Effect of Valsartan.
- Published in:
- Russian Journal of Genetics, 2023, v. 59, p. 74, doi. 10.1134/S1022795423130136
- By:
- Publication type:
- Article
Efficacy and Safety Comparative of Sacubitril/Valsartan vs. Olmesartan in the Treatment of hypertension: A Meta-analysis of RCTs.
- Published in:
- American Journal of Hypertension, 2023, v. 36, n. 12, p. 643, doi. 10.1093/ajh/hpad075
- By:
- Publication type:
- Article
Utilization patterns of cardiovascular medications in patients with diabetes mellitus; a retrospective cross-sectional study, 2013-17.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2023, v. 31, n. 2, p. 259, doi. 10.1007/s40199-023-00481-z
- By:
- Publication type:
- Article
Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 4, p. 397, doi. 10.1007/s40268-023-00438-2
- By:
- Publication type:
- Article
ΔRDW Could Predict Major Adverse Cardiovascular Events in Patients with Heart Failure with Reduced Ejection Fraction After Sacubitril/Valsartan Treatment.
- Published in:
- International Journal of General Medicine, 2023, v. 16, p. 5989, doi. 10.2147/IJGM.S444585
- By:
- Publication type:
- Article
Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension.
- Published in:
- Journal of Geriatric Cardiology, 2023, v. 20, n. 12, p. 855, doi. 10.26599/1671-5411.2023.12.005
- By:
- Publication type:
- Article
Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy.
- Published in:
- Molecular & Cellular Biochemistry, 2023, v. 478, n. 12, p. 2645, doi. 10.1007/s11010-023-04690-7
- By:
- Publication type:
- Article
A study of the efficacy of sacubitril/valsartan plus dapagliflozin combination treatment in pulmonary arterial hypertension due to left heart disease.
- Published in:
- Perfusion, 2023, v. 38, n. 8, p. 1697, doi. 10.1177/02676591221127924
- By:
- Publication type:
- Article
Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril/Valsartan among Patients with Heart Failure.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 11, p. 2568, doi. 10.3390/pharmaceutics15112568
- By:
- Publication type:
- Article
Kidneys in heart failure: Impact of flozins.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2023, v. 81, n. 11, p. 1071, doi. 10.33963/v.kp.97844
- By:
- Publication type:
- Article
Effect of combining valsartan and amlodipine in the treatment of type 2 diabetes mellitus complicated by hypertension.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2023, v. 22, n. 11, p. 2341, doi. 10.4314/tjpr.v22i11.14
- By:
- Publication type:
- Article
Exploration of the Mechanism of Valsartan Treatment in Chronic Renal Failure: Network Pharmacology and Experimental Validation.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2023, p. 1, doi. 10.1155/2023/4837743
- By:
- Publication type:
- Article
The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6247, doi. 10.3390/jcm12196247
- By:
- Publication type:
- Article
Development and Evaluation of Microemulsion Formualatons of Valsartan for Solubility Enhancement.
- Published in:
- Journal of Drug Delivery & Therapeutics, 2023, v. 13, n. 10, p. 117, doi. 10.22270/jddt.v13i10.5990
- By:
- Publication type:
- Article
Initiation, treatment response evaluation, and safety monitoring of angiotensin receptor/neprilysin inhibitors (Sacubitril/Valsartan) in the management of heart failure in India: An expert group recommendations.
- Published in:
- Journal of Indian College of Cardiology, 2023, v. 13, n. 4, p. 141, doi. 10.4103/jicc.jicc_22_23
- By:
- Publication type:
- Article
Pharmacokinetics and safety of highly variable valsartan in single-pill combination with amlodipine versus its generic formulation: a randomized, three-cycle, three-sequence, partially replicated crossover phase I bioequivalence clinical trial.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1264321
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan on brain natriuretic peptide level and prognosis of acute cerebral infarction.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291754
- By:
- Publication type:
- Article
Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran.
- Published in:
- Health Economics Review, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13561-023-00457-4
- By:
- Publication type:
- Article
Heart Failure Without a Reduced Ejection Fraction.
- Published in:
- American Journal of Managed Care, 2023, p. S187, doi. 10.37765/ajmc.2023.89417
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1173, doi. 10.1007/s00228-023-03527-y
- By:
- Publication type:
- Article
Effectiveness of Valsartan's Single-Pill Combination Therapies on Blood Pressure Control in Hypertensive Patients: Malaysian Single-Centre Real-World Experience.
- Published in:
- Malaysian Journal of Medical Sciences, 2023, v. 30, n. 5, p. 116, doi. 10.21315/mjms2023.30.5.10
- By:
- Publication type:
- Article